mac

Main Site "Silo"

Alissa Nana Li, PhD

Postdoctoral Fellow

Alissa joined the Seeley Selective Vulnerability Research Laboratory in 2011 as a post-doctoral fellow. Her background is in neurodegeneration research. Alissa completed a BSc degree with honors in biomedical science in 2004 and a PhD degree in anatomy in 2009 from the University of Auckland, New Zealand, where she investigated the variable pattern of cortical neuronal loss in Huntington’s disease. In the Seeley lab she is investigating the selective vulnerability of von Economo neurons (VENs) in frontotemporal dementia.

Allen Lee

Research Coordinator

Allen Lee graduated from UC San Diego in 2009 with a bachelor of science degree in physiology and neuroscience. At UCSD he pursued an interest in psychology and the brain by minoring in psychology and working with a great team in a psychology laboratory. Through that he had the opportunity to work in clinical and neuropsychological research with Parkinson's disease patients under a neurologist at the VA Medical Hospital. Allen has also done clinical research at the UCSD Medical Center Emergency Department that furthered his passion in medicine.

Allen joined the Memory and Aging Center in July 2010. He helps coordinate for the Chinese participants in the Alzheimer's Disease Research Center's study New Approaches to Dementia Heterogeneity, which longitudinally follows individuals in hopes of developing new ways to improve early detection and clinical care for patients with dementia.

Besides long walks on the beach, Allen enjoys learning new languages and playing all kinds of sports, especially tennis and basketball.

Norbert Lee

Staff Research Associate

Norbert Lee joined Dr. Seeley's Selective Vulnerability Research Laboratory as a Staff Research Associate in 2010. He assists with brain banking and other histology technician functions.

Shubir Dutt

Imaging Core Associate

Shubir Dutt works with the Imaging Core within the UCSF Memory and Aging Center.

Window into the Brain with Adam Boxer, MD, PhD

video: 
See video

Many researchers are finding that by the time a patient seeks treatment for symptoms of Alzheimer's disease, it's often too late for the available drugs to have an effect. Dr. Adam Boxer's lab is studying very precise eye tracking methods to gauge mental fitness and identify cognitive decline decades before the first symptoms appear.

David Perry, MD

Neurology Fellow

Dr. Perry graduated from medical school at Georgetown University in Washington, DC. He completed an internship in internal medicine and residency in neurology at the Mayo Clinic in Rochester, Minnesota where he also researched obsessive-compulsive features in dementia. He is a clinical instructor and fellow in behavioral neurology at the Memory and Aging Center and participates in the evaluation and treatment of patients in the MAC clinic.

His current area of research interest is the impact of neurodegenerative illness on reward processing.

Jennifer S. Yokoyama, PhD

Postdoctoral Scholar - Genetics

Jennifer Yokoyama obtained her PhD in pharmaceutical sciences and pharmacogenomics from UCSF in December 2010. Under the tutelage of Dr. Steven Hamilton (Department of Psychiatry and Institute for Human Genetics), her dissertation comprised work completed within the context of the Canine Behavioral Genetics Project. The overarching goal of the project is to leverage the simplified genetic structure in pure breeds of dog to glean novel information on canine neuropsychiatric disorders that are analogous to complex human diseases. Utilizing community-based DNA samples from domestic, purebreed dogs, Dr. Yokoyama performed genome-wide surveys for genetic risk loci underlying the canine anxiety disorder noise phobia, as well as for loci underlying adult-onset deafness in Border collies.

Dr. Yokoyama is currently a postdoctoral fellow at the Memory and Aging Center, where she is investigating genetic risk for neurodegenerative disease. Specifically, she is interested in the effect genotype can have on brain physiology, behavior and cognition in healthy adults, and how this may relate to increased vulnerability to (or protection from) disease processes in later stages of life. She is also particularly interested in understanding how these effects may differ across diverse ethnic populations. Dr. Yokoyama's long-term goal is to understand how variation across the entire genome confers risk for particular types of neurodegeneration for purposes of early treatment and therapeutic intervention.

Syndicate content